Bilimsel çalışmalar

Doç. Dr. İstemi Serin

130 yayın. Her yayının yanında bilginin kaynağı yazar.

Profile dön

  1. Early-onset VEXAS syndrome mimicking orbital cellulitis and successfully treated with allogeneic hematopoietic stem cell transplantation

    Journal of Hematopathology, 2026

    DOI 10.1007/s12308-026-00741-2 PMID 42836952 Kaynak: OpenAlex

  2. Interpretation of Hereditary Thrombophilia Test Results and Anticoagulation Decisions Across Specialties: A Scenario-Based Physician Survey

    Cerrahpaşa Medical Journal, 2026

    DOI 10.5152/cjm.2026.26099 Açık erişimli tam metinKaynak: ORCID

  3. Specialty Based Variations in the Clinical Use and Interpretation of Genetic Thrombosis Panels

    European Respiratory Journal, 2026

    DOI 10.1183/13993003.congress-2026.pa931 Kaynak: OpenAlex

  4. Comparative Prognostic Performance of Nutritional Indices in Acute Myeloid Leukemia

    Journal of Clinical Medicine, 2026

    DOI 10.3390/jcm15166179 PMID 42652583 Açık erişimli tam metinKaynak: ORCID

  5. Comparative Prognostic Performance of Nutritional and Inflammatory Indices in Diffuse Large B-Cell Lymphoma

    Journal of Clinical Medicine, 2026

    DOI 10.3390/jcm15124703 PMID 42355871 Açık erişimli tam metinKaynak: ORCID

  6. Prognostic Value of Baseline ¹⁸F-FDG PET/CT Metabolic Tumor Burden in Multiple Myeloma

    Research Square, 2026

    DOI 10.21203/rs.3.rs-11025606/v1 Açık erişimli tam metinKaynak: OpenAlex

  7. The prognostic value of the HALP score among patients diagnosed with Hodgkin lymphoma

    PubMed Central, 2026

    DOI 10.1097/md.0000000000051347 Açık erişimli tam metinKaynak: OpenAlex

  8. Isotretinoin-induced phenotypic shift from severe asthma to eosinophilic granulomatosis with polyangiitis

    Rheumatology, 2026

    DOI 10.1093/rheumatology/keag212 PMID 41999220 Kaynak: ORCID

  9. Macrophage Activation Syndrome Following Vaccination After HSCT

    Transplant Infectious Disease, 2026

    DOI 10.1111/tid.70167 PMID 41531145 Kaynak: ORCID

  10. ULK4 and CDKN2A polymorphisms influence the risk of developing monoclonal gammopathy of undetermined significance

    International Journal of Cancer, 2026

    DOI 10.1002/ijc.70427 PMID 41813586 Açık erişimli tam metinKaynak: OpenAlex

  11. HIV-negative KSHV/HHV8-associated multicentric Castleman disease with concurrent Kaposi sarcoma and POEMS-like manifestations

    Journal of Hematopathology, 2026

    DOI 10.1007/s12308-026-00722-5 PMID 42501235 Kaynak: OpenAlex

  12. Integrated Prognostic Modelling with the CALLY Index and Interim PET/CT in Hodgkin Lymphoma

    Cancers, 2026

    DOI 10.3390/cancers18193205 PMID 42882899 Açık erişimli tam metinKaynak: OpenAlex

  13. Periorbital Purpura and Fatigue in a Man Aged 57 Years

    JAMA Cardiology, 2026

    DOI 10.1001/jamacardio.2026.3614 PMID 42873523 Kaynak: OpenAlex

  14. Effects of Hydroxyurea Therapy on Inflammatory Markers and Indices in Patients with BCR-ABL Negative Myeloproliferative Neoplasms

    Istanbul Medical Journal, 2026

    DOI 10.4274/imj.galenos.2026.86382 Açık erişimli tam metinKaynak: OpenAlex

  15. Myth or reality: Graft versus host disease after autologous hematopoietic cell transplantation, a multicentre experience

    Transplant Immunology, 2025

    DOI 10.1016/j.trim.2025.102286 PMID 40907722 Kaynak: OpenAlex

  16. The Outcomes of Newly Diagnosed Multiple Myeloma Patients With Concurrent or Previous Solid Tumor History

    Clinical Lymphoma Myeloma & Leukemia, 2025

    DOI 10.1016/j.clml.2025.10.006 PMID 41206323 Kaynak: OpenAlex

  17. Follicular Lymphoma: Frequency and Timing of Treatment: Single Center Experience

    Istanbul Medical Journal, 2025

    DOI 10.4274/imj.galenos.2025.20788 Açık erişimli tam metinKaynak: OpenAlex

  18. Outcomes of Brentuximab Vedotin Monotherapy in Refractory/Relapsed Classical Hodgkin’s Lymphoma: A Multi-Center Retrospective Study on Survival and Safety

    Indian Journal of Hematology and Blood Transfusion, 2025

    DOI 10.1007/s12288-025-02093-w PMID 42040698 1 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  19. Metabolic syndrome and effect of gene polymorphisms: ADIPOQ, AGT, AGTR1, AGTR2, ApoC-III, NR3C1 and GNB3 gene polymorphisms

    Molecular Biology Reports, 2025

    DOI 10.1007/s11033-025-10518-y PMID 40272664 1 atıf (Europe PMC) Kaynak: OpenAlex

  20. Effect of Altitude on Polycythemia Vera: Is it Necessary to Change Limits?

    High Altitude Medicine & Biology, 2025

    DOI 10.1089/ham.2025.0001 PMID 40340428 Kaynak: ORCID

  21. Serum Erythropoietin Level in Polycythemia Vera: Is a New Cut-Off Possible?

    Indian Journal of Hematology and Blood Transfusion, 2025

    DOI 10.1007/s12288-025-01990-4 PMID 41084575 Açık erişimli tam metinKaynak: ORCID

  22. Clinical implication of anemia in older patients with dementia with lewy bodies

    Aging Clinical and Experimental Research, 2025

    DOI 10.1007/s40520-025-02958-0 PMID 39964627 7 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

  23. Effectiveness of Gilteritinib Beyond Second‐Line Therapy in Relapsed/Refractory FLT3 ‐Mutated Acute Myeloid Leukemia: A Real‐World Multicenter Study of 171 Patients

    American Journal of Hematology, 2025

    DOI 10.1002/ajh.70142 PMID 41273181 2 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

  24. Real-world effectiveness of gilteritinib beyond second-line therapy in relapsed/refractory FLT3-mutated acute myeloid leukemia: A european multicenter study of 171 patients

    Blood, 2025

    DOI 10.1182/blood-2025-1662 1 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

  25. The Effect of Bone Marrow CD4/CD8 Ratio on Lymphoma Response and Survival: Single Center Experience

    Istanbul Medical Journal, 2025

    DOI 10.4274/imj.galenos.2025.84760 Açık erişimli tam metinKaynak: OpenAlex

  26. The role of angiotensinogen, angiotensin II receptor type I and type II receptor polymorphisms (AGTR2 rs11091046, AGT rs699, AGTR1 rs5186, and AGT rs4762) in multiple myeloma

    Discover Oncology, 2025

    DOI 10.1007/s12672-025-03443-w PMID 40836159 Açık erişimli tam metinKaynak: OpenAlex

  27. The clinical significance of p53 and vascular endothelial growth factor in COVID-19 cases

    Medicine, 2025

    DOI 10.1097/md.0000000000044378 PMID 41054124 Açık erişimli tam metinKaynak: OpenAlex

  28. The connection between anemia and limitations in daily activities among older males: the critical role of dynapenia

    Aging Clinical and Experimental Research, 2024

    DOI 10.1007/s40520-024-02859-8 PMID 39460859 6 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  29. Polypharmacy Experience in Geriatric Hematology

    Eskisehir Medical Journal Eskisehir City Hospital, 2024

    DOI 10.48176/esmj.2024.166 Açık erişimli tam metinKaynak: OpenAlex

  30. Acinetobacter baumannii in Hematology Practice: Clinical Factors Affecting the Course of Infection

    Acta haematologica oncologica Turcica., 2024

    DOI 10.4274/ahot.galenos.2024.2024-9-3 Açık erişimli tam metinKaynak: OpenAlex

  31. Brentuximab Vedotin Monotherapy in Relapsed/Refractory T Cell Lymphoma Setting-Real Life Data

    Hitit Medical Journal, 2024

    DOI 10.52827/hititmedj.1320606 Açık erişimli tam metinKaynak: OpenAlex

  32. The role of immune checkpoint inhibitors: Variable number of tandem repeat (VNTR) polymorphism in the second exon of the P‐selectin glycoprotein ligand‐1 (PSGL‐1) gene polymorphism in multiple myeloma

    Molecular Carcinogenesis, 2024

    DOI 10.1002/mc.23787 PMID 38953715 Kaynak: ORCID

  33. How Effective are leptin Gene Polymorphisms and Methylation during the Course of Multiple Myeloma?

    Cytology and Genetics, 2024

    DOI 10.3103/s0095452724040091 Kaynak: ORCID

  34. Germline CEBPA Mutation as a Rare Cause of Chronic Neutropenia

    Indian Journal of Hematology and Blood Transfusion, 2024

    DOI 10.1007/s12288-023-01725-3 PMID 39011240 Açık erişimli tam metinKaynak: ORCID

  35. Etiological Evaluation and Mortality of Patients with Renal Artery Stenosis: A Single-Center Experience

    Istanbul Medical Journal, 2024

    DOI 10.4274/imj.galenos.2024.53060 Açık erişimli tam metinKaynak: ORCID

  36. The effect of leptin gene polymorphisms (LEP rs7799039 and LEPR rs1137101) on febrile neutropenia

    Heliyon, 2024

    DOI 10.1016/j.heliyon.2024.e28788 PMID 38586343 3 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID

  37. Relationship of LEP, LEPR Variants, and LEP Methylation with Multiple Myeloma and Prognosis

    Istanbul Medical Journal, 2024

    DOI 10.4274/imj.galenos.2024.09365 Açık erişimli tam metinKaynak: ORCID

  38. Lymphocyte Level at Diagnosis in Hodgkin lymphoma: Could It be an Indicator of the Stage at Initial Diagnosis?

    International Journal of Hematology-Oncology and Stem Cell Research, 2024

    DOI 10.18502/ijhoscr.v18i1.14741 PMID 38680717 1 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

  39. How complicated can be a case with immune thrombocytopenic purpura?: postsplenectomy arterial thrombosis

    Blood Coagulation & Fibrinolysis, 2024

    DOI 10.1097/mbc.0000000000001290 PMID 38407854 Kaynak: OpenAlex

  40. Impact of Eltrombopag Therapy in Different Lines of Treatment on Response in Patients with Immune Thrombocytopenia

    Istanbul Medical Journal, 2024

    DOI 10.4274/imj.galenos.2024.24295 Açık erişimli tam metinKaynak: OpenAlex

  41. Plerixafor in autologous stem cell transplantation: Does it affect engraftment kinetics?

    Transfusion and Apheresis Science, 2023

    DOI 10.1016/j.transci.2023.103809 PMID 37690861 2 atıf (Europe PMC) Kaynak: OpenAlex

  42. PB2702: POLYPHARMACY IN HEMATOLOGY PRACTISE: A SINGLE CENTER EXPERIENCE

    HemaSphere, 2023

    DOI 10.1097/01.hs9.0000977480.17704.d5 1 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

  43. A Real-Life Turkish Experience of Ruxolitinib in Polycythemia Vera

    Istanbul Medical Journal, 2023

    DOI 10.4274/imj.galenos.2023.66742 1 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

  44. The effect of DNA repair gene variants on COVID-19 disease: susceptibility, severity, and clinical course

    Nucleosides Nucleotides & Nucleic Acids, 2023

    DOI 10.1080/15257770.2023.2172183 PMID 36708261 2 atıf (Europe PMC) Kaynak: OpenAlex

  45. Real-world data on the effectiveness and safety of Ixazomib-Lenalidomide-Dexamethasone therapy in relapsed/refractory multiple myeloma patients: a multicenter experience in Turkey

    Journal of Chemotherapy, 2023

    DOI 10.1080/1120009x.2023.2208439 PMID 37211906 3 atıf (Europe PMC) Kaynak: ORCID

  46. AAT: does it have a place in acute leukemia?

    Biomarkers in Medicine, 2023

    DOI 10.2217/bmm-2023-0415 PMID 38197403 Kaynak: ORCID

  47. Gilteritinib (XOSPATA®) in Turkey: Early Access Program Results

    Mediterranean Journal of Hematology and Infectious Diseases, 2023

    DOI 10.4084/mjhid.2023.031 PMID 37180209 4 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID

  48. Pre-treatment neutrophil-lymphocyte and monocyte-lymphocyte ratios give clues about response, survival, and recurrence in diffuse large B-cell lymphoma

    Archive of Oncology, 2023

    DOI 10.2298/aoo201122003d 2 atıf (OpenAlex) Açık erişimli tam metinKaynak: ORCID

  49. Evaluation of Hepatitis C in 20 Years: A Turkish Experience

    Bagcilar Medical Bulletin, 2023

    DOI 10.4274/bmb.galenos.2023.2023-01-07 1 atıf (OpenAlex) Açık erişimli tam metinKaynak: ORCID

  50. Effect of interleukin-2 (IL-2) polymorphisms on multiple myeloma: IL-2RA rs2104286, IL-2 rs2069762 and rs2069763 polymorphisms

    Cytokine, 2023

    DOI 10.1016/j.cyto.2023.156401 PMID 37832160 1 atıf (Europe PMC) Kaynak: ORCID